Centocor Ortho Biotech Inc. Sponsors Award Honoring the Work of Oncology
SAN ANTONIO, May 1 /PRNewswire/ -- The winner and finalists of CURE magazine's 2009 Extraordinary Healer Award for Oncology Nursing, sponsored by Centocor Ortho Biotech Inc., were announced during a special reception at the Oncology Nursing Society's (ONS) 34th Annual Congress.
More than 150 cancer patients and caregivers submitted nominations. The winner, Christine Wilson, RN, Nationwide Children's Hospital (Columbus, Ohio), was announced during the third annual award reception alongside her former patient, Delaney Diggs, and Delaney's mother, Renee La Forest. Christine, who treated Delaney when she was six years old, is the first pediatric nurse to be a finalist for the award and was described as "inspirational" with "boundless energy and enthusiasm" who "remained a consummate professional while bringing a positive spirit of hope and encouragement."
In addition to Christine, two finalists, Nadeen Robinson, RN, BSN, OCN, New York-Presbyterian Hospital/
"I am truly honored to receive the Extraordinary Healer Award, and it is very gratifying to see the oncology nursing profession recognized," said Christine Wilson, RN, Nationwide Children's Hospital, Columbus, Ohio. "Oncology nurses strive to make a difference in the lives of their patients, and what I do is just a representation of the important work that all oncology nurses do across the country every day."
Peggy Fleming, former ice skater, Olympic gold medalist and breast cancer survivor, was mistress of ceremonies for the event, which honors oncology nurses who demonstrate unwavering compassion and expertise. The winner and two finalists exemplify the exceptional efforts that nurses make in improving the lives of the patients and families with whom they work. Since 2007, more than 400 cancer patients and caregivers have submitted essays nominating oncology nurses who made an important impact on their lives.
"The Extraordinary Healer Award for Oncology Nursing provides patients the opportunity to thank their nurses for their devotion and exemplary work, and for making a difference in their lives," said Kathy LaTour, Editor-at-Large, CURE magazine. "It is heartwarming to see so many patients recognize the commitment of their nurses."
The winning essay will be featured in the Summer 2009 issue of CURE, a quarterly magazine for cancer patients, survivors and caregivers. A Podcast of the essayists reading their nominations will be available on www.curetoday.com beginning June 17, 2009. In addition, further information about the award and winning essays can be found on CURE's Facebook page at http://www.facebook.com/home.php#/pages/CURE-magazine/49288984808.
"We are pleased to continue our support of such a unique program to honor well-deserving oncology nurses," said Kim Taylor, President, Centocor Ortho Biotech Inc. "Centocor Ortho Biotech is committed to helping patients throughout their cancer journey, and is proud to sponsor an award that recognizes the meaningful impact that oncology nurses have on their patients."
CURE magazine is a free, award-winning publication from Dallas-based CURE Media Group - the national source for cancer patient education. By combining science and humanity, CURE helps patients, survivors and caregivers navigate the cancer journey and understand their diagnosis and treatment, while providing tools to cope during and after cancer - ultimately helping them to live the life they aspire to. Through the magazine, an annual resource guide for the newly diagnosed, books, and a new and interactive website, CURE provides a wealth of resources for everyone on the cancer journey. For more information, visit www.curetoday.com.
About Centocor Ortho Biotech Inc.
Centocor Ortho Biotech Inc. redefines the standard of care in immunology, nephrology, and oncology. The company was formed when Centocor, Inc. and Ortho Biotech Inc. were consolidated in late 2008, and was renamed Centocor Ortho Biotech Inc. Built upon a pioneering history, Centocor Ortho Biotech Inc. harnesses innovations in large-molecule and small-molecule research to create important new therapeutic options. Beyond its innovative medicines, Centocor Ortho Biotech is at the forefront of developing education and public policy initiatives to ensure patients and their families, caregivers, advocates, and healthcare professionals have access to the latest treatment information, support services, and quality care.
|SOURCE Centocor Ortho Biotech Inc.|
Copyright©2009 PR Newswire.
All rights reserved